Global Vaccine Market Report By Technology (Live, Toxoid, Recombinant), By Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), By Route (IM, SC, ID, Oral), By Patient (Pediatric, Adult) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211825
March 2020
Report Formats:

The global demand for Vaccine Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Vaccines are the substance that protects people from diseases by producing immunity to a specific disease. It contains a dead or weakened version of microbes; these microbes stimulate immune system to produce antibodies. Most vaccines are given by injection, nasally, or by mouth. Depending on strategies utilised to activate or stimulate immune system,vaccines are classified into different types:inactivated, attenuated, toxoid, subunit, experimental, valence, heterotypic and conjugate. There are number of the vaccines under development and yet to commercialise.
 
Market Dynamics
 
Global eradication goals and population expansion are predicted to drive the growth of the vaccine market. Annually, an estimated 2-3 million child deaths and 600,000 adult deaths are prevented by vaccination. Still, there are many diseases that claim millions of lives yearly and for which effective vaccines are not yet available this is giving rise to research and development of the new and improved vaccine. High-income countries are major purchasers of vaccine constituting 82% of global vaccine sales. However, vaccine wastage is identified as a major problem to affect market revenue. There is also another concern that some countries have insufficient funds to buy vaccine while some countries don't have resource or mandate required to conduct the vaccine development due to poor functioning national authorities. This affects the future viability of the vaccine. To assess these factors affecting growth, WHO is taking various measures by developing a set of tools to support programmes and partners to measure and address under-vaccination.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Vaccine.
 
Market Segmentation
 
The entire Vaccine market has been sub-categorized into technology, disease, patient and route. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Technology

  • Live
  • Toxoid
  • Recombinant
 
By Disease
  • Pneumococcal
  • Influenza
  • DTP
  • Rotavirus
  • TT
  • Polio
  • MMR
  • Varicella
  • Dengue
  • TB
  • Shingles
  • Rabies
  • Other
 
By Route
  • IM
  • SC
  • ID
  • Oral
 
By Patient
  • Pediatric
  • Adult
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Vaccine Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine market include Glaxosmithkline PLC, Pfizer, Inc, Merck & Co., Inc., Sanofi Pasteur SA, and CSL Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Vaccine Market
       2.2. Global Vaccine Market Snapshot
 
3 . VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Vaccine Market
       3.3. Market Restraints of Vaccine Market
       3.4. Opportunities of Vaccine Market
       3.5. Trends of Vaccine Market
       3.6. Porter’s Five Force Analysis of Vaccine Market
       3.7. Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology
           3.7.2 Market Attractive Analysis by Disease
           3.7.3 Market Attractive Analysis by Route
           3.7.4 Market Attractive Analysis by Patient
           3.7.5 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Vaccine Value Chain Analysis
       4.2. Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Vaccine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL VACCINE MARKET ANALYSIS BY TECHNOLOGY
       5.1 Overview by Technology
       5.2 Global Vaccine Market Analysis by Technology
       5.3 Market Analysis of Live by Regions
       5.4 Market Analysis of Toxoid by Regions
       5.5 Market Analysis of Recombinant by Regions
 
6 . GLOBAL VACCINE MARKET ANALYSIS BY DISEASE
       6.1 Overview by Disease
       6.2 Global Vaccine Market Analysis by Disease
       6.3 Market Analysis of Pneumococcal by Regions
       6.4 Market Analysis of Influenza by Regions
       6.5 Market Analysis of DTP by Regions
       6.6 Market Analysis of Rotavirus by Regions
       6.7 Market Analysis of TT by Regions
       6.8 Market Analysis of Polio by Regions
       6.9 Market Analysis of MMR by Regions
       6.10. Market Analysis of Varicella by Regions
       6.11 Market Analysis of Dengue by Regions
       6.12 Market Analysis of TB by Regions
       6.13 Market Analysis of Shingles by Regions
       6.13 Market Analysis of Rabies by Regions
       6.13 Market Analysis of Other by Regions
 
7 . GLOBAL VACCINE MARKET ANALYSIS BY ROUTE
       7.1 Overview by Route
       7.2 Global Vaccine Market Analysis by Route
       7.3 Market Analysis of IM by Regions
       7.4 Market Analysis of SC by Regions
       7.5 Market Analysis of ID by Regions
       7.6 Market Analysis of Oral by Regions
 
8 . GLOBAL VACCINE MARKET ANALYSIS BY PATIENT
       8.1 Overview by Patient
       8.2 Global Vaccine Market Analysis by Patient
       8.3 Market Analysis of Pediatric by Regions
       8.4 Market Analysis of Adult by Regions
 
9 . GLOBAL VACCINE MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Vaccine Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Vaccine Market Estimate by Market Segment
           9.4.3. Europe Vaccine Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Vaccine Market Estimate by Market Segment
           9.5.3. Asia Pacific Vaccine Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Vaccine Market Estimate by Market Segment
           9.6.3. Latin America Vaccine Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Vaccine Market Estimate by Market Segment
           9.7.3. Middle East & Africa Vaccine Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 COMPETITIVE LANDSCAPE OF THE VACCINE COMPANIES
       10.1. Vaccine Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 COMPANY PROFILES OF VACCINE INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Glaxosmithkline PLC
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Pfizer, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Merck & Co., Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Sanofi Pasteur SA
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. CSL Limited
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Vaccine Market Snapshot
  • Drivers of The Global Vaccine Market Impact Analysis
  • Restraints of The Global Vaccine Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Vaccine Market Analysis by Technology (USD MN)
  • Global Vaccine Market Analysis in Live by Geography (USD MN)
  • Global Vaccine Market Analysis in Toxoid by Geography (USD MN)
  • Global Vaccine Market Analysis in Recombinant by Geography (USD MN)
  • Global Vaccine Market Analysis by Disease (USD MN)
  • Global Vaccine Market Analysis in Pneumococcal by Geography (USD MN)
  • Global Vaccine Market Analysis in Influenza by Geography (USD MN)
  • Global Vaccine Market Analysis in DTP by Geography (USD MN)
  • Global Vaccine Market Analysis in Rotavirus by Geography (USD MN)
  • Global Vaccine Market Analysis in TT by Geography (USD MN)
  • Global Vaccine Market Analysis in Polio by Geography (USD MN)
  • Global Vaccine Market Analysis in MMR by Geography (USD MN)
  • Global Vaccine Market Analysis in Varicella by Geography (USD MN)
  • Global Vaccine Market Analysis in Dengue by Geography (USD MN)
  • Global Vaccine Market Analysis in TB by Geography (USD MN)
  • Global Vaccine Market Analysis in Shingles by Geography (USD MN)
  • Global Vaccine Market Analysis in Rabies by Geography (USD MN)
  • Global Vaccine Market Analysis in Other by Geography (USD MN)
  • Global Vaccine Market Analysis by Route (USD MN)
  • Global Vaccine Market Analysis in IM by Geography (USD MN)
  • Global Vaccine Market Analysis in SC by Geography (USD MN)
  • Global Vaccine Market Analysis in ID by Geography (USD MN)
  • Global Vaccine Market Analysis in Oral by Geography (USD MN)
  • Global Vaccine Market Analysis by Patient (USD MN)
  • Global Vaccine Market Analysis in Pediatric by Geography (USD MN)
  • Global Vaccine Market Analysis in Adult by Geography (USD MN)
  • Global Vaccine Market by Geography (USD MN)
  • North America Vaccine Market Analysis by Technology (USD MN)
  • North America Vaccine Market Estimate by Disease (USD MN)
  • North America Vaccine Market Estimate by Route (USD MN)
  • North America Vaccine Market Estimate by Patient (USD MN)
  • North America Vaccine Market Estimate by Country (USD MN)
  • United State Vaccine Market Analysis by Technology (USD MN)
  • United State Vaccine Market Estimate by Disease (USD MN)
  • United State Vaccine Market Analysis by Route (USD MN)
  • United State Vaccine Market Estimate by Patient (USD MN)
  • Rest of North America Vaccine Market Analysis by Technology (USD MN)
  • Rest of North America Vaccine Market Estimate by Disease (USD MN)
  • Rest of North America Vaccine Market Estimate by Route(USD MN)
  • Rest of North America Vaccine Market Estimate by Patient(USD MN)
  • Europe Vaccine Market Analysis by Technology (USD MN)
  • Europe Vaccine Market Estimate by Disease (USD MN)
  • Europe Vaccine Market Estimate by Route (USD MN)
  • Europe Vaccine Market Estimate by Patient (USD MN)
  • Europe Vaccine Market Estimate by Country (USD MN)
  • United Kingdom Vaccine Market Analysis by Technology (USD MN)
  • United Kingdom Vaccine Market Estimate by Disease (USD MN)
  • United Kingdom Vaccine Market Estimate by Route (USD MN)
  • United Kingdom Vaccine Market Estimate by Patient (USD MN)
  • France Vaccine Market Analysis by Technology (USD MN)
  • France Vaccine Market Estimate by Disease (USD MN)
  • France Vaccine Market Estimate by Route (USD MN)
  • France Vaccine Market Estimate by Patient (USD MN)
  • Germany Vaccine Market Analysis by Technology (USD MN)
  • Germany Vaccine Market Estimate by Disease (USD MN)
  • Germany Vaccine Market Estimate by Route (USD MN)
  • Germany Vaccine Market Estimate by Patient (USD MN)
  • Rest of Europe Vaccine Market Analysis by Technology (USD MN)
  • Rest of Europe Vaccine Market Estimate by Disease (USD MN)
  • Rest of Europe Vaccine Market Estimate by Route (USD MN)
  • Rest of Europe Vaccine Market Estimate by Patient (USD MN)
  • Asia Pacific Vaccine Market Analysis by Technology (USD MN)
  • Asia Pacific Vaccine Market Estimate by Disease (USD MN)
  • Asia Pacific Vaccine Market Estimate by Route (USD MN)
  • Asia Pacific Vaccine Market Estimate by Patient (USD MN)
  • Asia Pacific Vaccine Market Estimate by Country (USD MN)
  • China Vaccine Market Analysis by Technology (USD MN)
  • China Vaccine Market Estimate by Disease (USD MN)
  • China Vaccine Market Estimate by Route (USD MN)
  • China Vaccine Market Estimate by Patient (USD MN)
  • Japan Vaccine Market Analysis by Technology (USD MN)
  • Japan Vaccine Market Estimate by Disease (USD MN)
  • Japan Vaccine Market Estimate by Route (USD MN)
  • Japan Vaccine Market Estimate by Patient(USD MN)
  • India Vaccine Market Analysis by Technology (USD MN)
  • India Vaccine Market Estimate by Disease (USD MN)
  • India Vaccine Market Estimate by Route (USD MN)
  • India Vaccine Market Estimate by Patient (USD MN)
  • Rest of Asia Pacific Vaccine Market Analysis by Technology (USD MN)
  • Rest of Asia Pacific Vaccine Market Estimate by Disease (USD MN)
  • Rest of Asia Pacific Vaccine Market Estimate by Route (USD MN)
  • Rest of Asia Pacific Vaccine Market Estimate by Patient (USD MN)
  • Latin America Vaccine Market Analysis by Technology (USD MN)
  • Latin America Vaccine Market Estimate by Disease (USD MN)
  • Latin America Vaccine Market Estimate by Route (USD MN)
  • Latin America Vaccine Market Estimate by Patient (USD MN)
  • Latin America Vaccine Market Estimate by Country (USD MN)
  • Brazil Vaccine Market Analysis by Technology (USD MN)
  • Brazil Vaccine Market Estimate by Disease (USD MN)
  • Brazil Vaccine Market Estimate by Route (USD MN)
  • Brazil Vaccine Market Estimate by Patient (USD MN)
  • Rest of Latin America Vaccine Market Analysis by Technology (USD MN)
  • Rest of Latin America Vaccine Market Estimate by Disease (USD MN)
  • Rest of Latin America Vaccine Market Estimate by Route (USD MN)
  • Rest of Latin America Vaccine Market Estimate by Patient (USD MN)
  • Middle East & Africa Vaccine Market Analysis by Technology (USD MN)
  • Middle East & Africa Vaccine Market Estimate by Disease (USD MN)
  • Middle East & Africa Vaccine Market Estimate by Route (USD MN)
  • Middle East & Africa Vaccine Market Estimate by Patient (USD MN)
  • Middle East & Africa Vaccine Market Estimate by Country (USD MN)
  • Middle East Vaccine Market Analysis by Technology (USD MN)
  • Middle East Vaccine Market Estimate by Disease (USD MN)
  • Middle East Vaccine Market Estimate by Route (USD MN)
  • Middle East Vaccine Market Estimate by Patient (USD MN)
  • Africa Vaccine Market Analysis by Technology (USD MN)
  • Africa Vaccine Market Estimate by Disease (USD MN)
  • Africa Vaccine Market Estimate by Route (USD MN)
  • Africa Vaccine Market Estimate by Patient (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Vaccine Report
  • Market Research Process
  • Market Research Methodology
  • Global Vaccine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Disease
  • Market Attractiveness Analysis by Route
  • Market Attractiveness Analysis by Patient
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Vaccine Market Analysis by Technology (USD MN)
  • Global Vaccine Market Analysis in Live by Geography (USD MN)
  • Global Vaccine Market Analysis in Toxoid by Geography (USD MN)
  • Global Vaccine Market Analysis in Recombinant by Geography (USD MN)
  • Global Vaccine Market Analysis by Disease (USD MN)
  • Global Vaccine Market Analysis in Pneumococcal by Geography (USD MN)
  • Global Vaccine Market Analysis in Influenza by Geography (USD MN)
  • Global Vaccine Market Analysis in DTP by Geography (USD MN)
  • Global Vaccine Market Analysis in Rotavirus by Geography (USD MN)
  • Global Vaccine Market Analysis in TT by Geography (USD MN)
  • Global Vaccine Market Analysis in Polio by Geography (USD MN)
  • Global Vaccine Market Analysis in MMR by Geography (USD MN)
  • Global Vaccine Market Analysis in Varicella by Geography (USD MN)
  • Global Vaccine Market Analysis in Dengue by Geography (USD MN)
  • Global Vaccine Market Analysis in TB by Geography (USD MN)
  • Global Vaccine Market Analysis in Shingles by Geography (USD MN)
  • Global Vaccine Market Analysis in Rabies by Geography (USD MN)
  • Global Vaccine Market Analysis in Other by Geography (USD MN)
  • Global Vaccine Market Analysis by Route (USD MN)
  • Global Vaccine Market Analysis in IM by Geography (USD MN)
  • Global Vaccine Market Analysis in SC by Geography (USD MN)
  • Global Vaccine Market Analysis in ID by Geography (USD MN)
  • Global Vaccine Market Analysis in Oral by Geography (USD MN)
  • Global Vaccine Market Analysis by Patient (USD MN)
  • Global Vaccine Market Analysis in Pediatric by Geography (USD MN)
  • Global Vaccine Market Analysis in Adult by Geography (USD MN)
  • Latin America Vaccine Market by Revenue
  • Middle East & Africa Vaccine Market by Revenue
  • Recent Development in Vaccine Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials